BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang GQ, Zhao H, Wu JY, Li JY, Yan X, Wang G, Wu LL, Zhang XG, Shao Y, Wang Y, Jiao SC. Prolonged overall survival in gastric cancer patients after adoptive immunotherapy. World J Gastroenterol 2015; 21(9): 2777-2785 [PMID: 25759549 DOI: 10.3748/wjg.v21.i9.2777]
URL: https://www.wjgnet.com/1007-9327/full/v21/i9/2777.htm
Number Citing Articles
1
Ryan J. Slovak, Hyun S. Kim. Adoptive Cell Therapy for Gastrointestinal CancersDigestive Disease Interventions 2020; 4(04): 345 doi: 10.1055/s-0040-1718902
2
Riccardo Dolcetti, Valli De Re. Gastric Cancer In The Precision Medicine EraCurrent Clinical Pathology 2019; : 189 doi: 10.1007/978-3-030-04861-7_12
3
Sanjay Chandrasekaran, Christopher Ronald Funk, Troy Kleber, Chrystal M. Paulos, Mala Shanmugam, Edmund K. Waller. Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and –γFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.718621
4
Rilan Bai, Naifei Chen, Tingting Liang, Lingyu Li, Zheng Lv, Xiaomin Lv, Jiuwei Cui. Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00912
5
Xingmu Wang, Feiying Yang, Guangen Xu, Shuping Zhong. The roles of IL-6, IL-8 and IL-10 gene polymorphisms in gastric cancer: A meta-analysisCytokine 2018; 111: 230 doi: 10.1016/j.cyto.2018.08.024
6
Qingfang Zhao, Liang Cao, Lulu Guan, Liangyu Bie, Saiqi Wang, Bojian Xie, Xiaobing Chen, Xiaokun Shen, Feiling Cao. Immunotherapy for gastric cancer: dilemmas and prospectBriefings in Functional Genomics 2019; 18(2): 107 doi: 10.1093/bfgp/ely019
7
Shiyu Zhang, Huiying Yang, Xuelian Xiang, Li Liu, Huali Huang, Guodu Tang. BGN May be a Potential Prognostic Biomarker and Associated With Immune Cell Enrichment of Gastric CancerFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.765569
8
Suat BENEK, Şevki PEDÜK, Mehmet ZENGIN. Platelet-lymphocyte ratio predicts poor prognosis in stage II/III colon and rectum cancerJournal of Health Sciences and Medicine 2022; 5(2): 491 doi: 10.32322/jhsm.1056614
9
Dong Shen, Zhi-Hao Liu, Jia-Ning Xu, Fang Xu, Qin-Feng Lin, Feng Lin, Wei-Dong Mao. Efficacy of Adoptive Cellular Therapy in Patients With Gastric Cancer: A Meta-AnalysisImmunotherapy 2016; 8(8): 971 doi: 10.2217/imt.16.10
10
Daniela Cornelia Lazăr, Mihaela Flavia Avram, Ioan Romoșan, Mărioara Cornianu, Sorina Tăban, Adrian Goldiș. Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancerWorld Journal of Gastroenterology 2018; 24(32): 3583-3616 doi: 10.3748/wjg.v24.i32.3583
11
Yunxia Liu, Yefeng Xu, Yiqing Wang, Yongwei Yao, Jiewen Yang. Associations between interleukin gene polymorphisms and the risk of gastric cancer: A meta‐analysisClinical and Experimental Pharmacology and Physiology 2018; 45(12): 1236 doi: 10.1111/1440-1681.13021
12
Yizhen Chen, Yifan Chen, Song Tan, Yuanyuan Zheng, Shaolin Liu, Tao Zheng, Yulong Mi, Shentao Lin, Changshun Yang, Weihua Li. Visual analysis of global research on immunotherapy for gastric cancer: A literature mining from 2012 to 2022Human Vaccines & Immunotherapeutics 2023; 19(1) doi: 10.1080/21645515.2023.2186684
13
Mohamed Abozeid, Antonio Rosato, Roberta Sommaggio. Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent DevelopmentBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/5791262
14
Juan Du, Jia Wei, Yang Yang, Shu Su, Jie Shao, Fangjun Chen, Fanyan Meng, Zhengyun Zou, Baorui Liu. Disappearance of bone metastases in chemotherapy‑resistant gastric cancer treated with antigen peptide‑pulsed dendritic cell‑activated cytotoxic T lymphocyte immunotherapy: A case reportOncology Letters 2018;  doi: 10.3892/ol.2018.8781
15
Riccardo Dolcetti, Valli De Re, Vincenzo Canzonieri. Immunotherapy for Gastric Cancer: Time for a Personalized Approach?International Journal of Molecular Sciences 2018; 19(6): 1602 doi: 10.3390/ijms19061602
16
Keiichiro Mie, Terumasa Shimada, Hideo Akiyoshi, Akiyoshi Hayashi, Fumihito Ohashi. Change in peripheral blood lymphocyte count in dogs following adoptive immunotherapy using lymphokine-activated T killer cells combined with palliative tumor resectionVeterinary Immunology and Immunopathology 2016; 177: 58 doi: 10.1016/j.vetimm.2016.06.007
17
Jin Wang, Jinglei Qu, Zhi Li, Xiaofang Che, Jing Liu, Yuee Teng, Bo Jin, Mingfang Zhao, Lingyun Zhang, Yunpeng Liu, Xiujuan Qu. Combination of Platelet Count and Neutrophil–Lymphocyte Ratio as a Prognostic Marker to Predict Chemotherapeutic Response and Survival in Metastatic Advanced Gastric CancerBiomarkers in Medicine 2017; 11(10): 835 doi: 10.2217/bmm-2016-0288
18
Irene Sarkar, Subhadip Pati, Abhishek Dutta, Udit Basak, Gaurisankar Sa. T-memory cells against cancer: Remembering the enemyCellular Immunology 2019; 338: 27 doi: 10.1016/j.cellimm.2019.03.002
19
Barbara Mandriani, Eleonora Pelle', Gaetano Pezzicoli, Jonathan Strosberg, Daniel Abate-Daga, Attilio Guarini, Mauro Cives, Camillo Porta. Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectivesCancer Treatment Reviews 2021; 100: 102288 doi: 10.1016/j.ctrv.2021.102288
20
M. Gulubova, M. Hadzhi, M. Ignatova, D. Chonov, O. Balakan, M. Aydan, J. Ananiev. Novel Immunotherapeutic Approach in Gastric CancerActa Medica Bulgarica 2020; 47(2): 47 doi: 10.2478/amb-2020-0024
21
Jonathan E. Schoenhals, Tijana Skrepnik, Ugur Selek, Maria A. Cortez, Ailin Li, James W. Welsh. ImmunotherapyAdvances in Experimental Medicine and Biology 2017; 995: 53 doi: 10.1007/978-3-319-53156-4_3
22
Christo Kole, Nikolaos Charalampakis, Sergios Tsakatikas, Nikolaos-Iasonas Kouris, George Papaxoinis, Michalis V Karamouzis, Anna Koumarianou, Dimitrios Schizas. Immunotherapy for Gastric Cancer: A 2021 UpdateImmunotherapy 2022; 14(1): 41 doi: 10.2217/imt-2021-0103
23
Elnaz Faghfuri, Mahdi Abdoli Shadbad, Amir Hossein Faghfouri, Narges Soozangar. Cellular Immunotherapy in Gastric Cancer: Adoptive Cell Therapy and Dendritic Cell-Based VaccinationImmunotherapy 2022; 14(6): 475 doi: 10.2217/imt-2021-0285